UK investigator-led multicentre prospective RCT on efficacy & safety of LV unloading in high-risk PCI. Funded by @NIHRresearch; @kingscardio @CTU_LSHTM @bcis_uk

London, UK
Joined October 2020
📣 More @CHIP_BCIS3 data❗️ @TCTConference and @AHAScience 💥Health Economic Analysis: Sat 31Oct San Diego @hollymorgs 🪾mAFP and Coronary Microvascular Function: Mon 02Nov San Diego @SaadEzad 🫀Procedural myocardial injury, mAFP and CV death: Sat 07Nov Chicago @AishSinha1
3
3
6
1,937
Excited to share new results @TCTConference and @AHAScience❗️ @kingscardio @Kings_BHFCentre 💥 Impella in HR-PCI: analyses from @CHIP_BCIS3 trial 💥 VA-ECMO in SCAI D/E shock: HERACLES trial (IABP vs Impella unloading) 💥 Coronary Physiology Innovations (left main, CMD, AAOCA)
10
10
495
CHIP-BCIS3 retweeted
Getting excited for #TCT2026 and to present the @CHIP_BCIS3 health economic analysis - importantly how the different strategies and frequency of staged procedures impacted on cost and QOL..! ⚖️ 💰 @TCTConference @LSHTM @DrPeterOKane @VPanoulas @ALadwiniec @divaka_perera
📣 More @CHIP_BCIS3 data❗️ @TCTConference and @AHAScience 💥Health Economic Analysis: Sat 31Oct San Diego @hollymorgs 🪾mAFP and Coronary Microvascular Function: Mon 02Nov San Diego @SaadEzad 🫀Procedural myocardial injury, mAFP and CV death: Sat 07Nov Chicago @AishSinha1
8
17
831
CHIP-BCIS3 retweeted
In CHIP-BCIS3, elective MCS use was associated with higher CV ☠️ in patients undergoing HR-PCI, when compared against standard care. In our latest analysis, we investigate whether procedure-related myocardial injury was the missing 🧩 linking MCS use with CV ☠️ .
📣 More @CHIP_BCIS3 data❗️ @TCTConference and @AHAScience 💥Health Economic Analysis: Sat 31Oct San Diego @hollymorgs 🪾mAFP and Coronary Microvascular Function: Mon 02Nov San Diego @SaadEzad 🫀Procedural myocardial injury, mAFP and CV death: Sat 07Nov Chicago @AishSinha1
1
6
13
494
Grateful for the skill and dedication of @UKheartresearch + @CTU_LSHTM teams, @CHIP_BCIS3 group and @BCIS_uk network for these important analyses. Looking forward to sharing new insights #TCT2026 in San Diego and #ScientificSessions26 in Chicago, very soon!
📣 More @CHIP_BCIS3 data❗️ @TCTConference and @AHAScience 💥Health Economic Analysis: Sat 31Oct San Diego @hollymorgs 🪾mAFP and Coronary Microvascular Function: Mon 02Nov San Diego @SaadEzad 🫀Procedural myocardial injury, mAFP and CV death: Sat 07Nov Chicago @AishSinha1
6
17
536
BCIS Grand Rounds: ground-breaking research viewed through an inimitable @BCIS_uk lens! It’s an honour to participate in the first one, when I will dive deep into (and zoom out from) @CHIP_BCIS3 with the distinguished panel and live audience 16 Sep ‘26 at 1730BST. Pre-register👇🏽
Introducing BCIS Grand Rounds. Landmark trials, chief investigators and panel debates. First session this Wednesday 16 September, 17:30–18:30 focussed on CHIP – BCIS3 with Prof. Divaka Perera. Chaired by Prof. Julian Gunn. Panel: Prof. Simon Ray, Dr Jennifer Rossington, Dr Sohail Khan. Free to BCIS and BJCA members. Non-members: £50. Register: millbrook-events.co.uk/event… #BCIS #GrandRounds #CHIP #InterventionalCardiology
6
11
905
CHIP-BCIS3 retweeted
Immediate past president of the BJCA, Holly Morgan, shares details of BCIS Grand Rounds — a new webinar series bringing landmark clinical trials to life. First up: CHIP-BCIS3, 16th September, 17:30-18:30. Recorded in a dedicated studio and presented in a dynamic, podcast-style format, each session follows a chief investigator through a landmark trial, before a panel of leading interventional cardiologists puts them to the test. First instalment: 🎤Presented by Prof. Divaka Perera 🪑Chaired by Prof. Julian Gunn 👥Panel: Prof. Simon Ray · Dr Jennifer Rossington · Dr Sohail Khan Free for BCIS UK and international members, and BJCA members. £50 for non-members. This is the first of four Grand Rounds webinars — don't miss the launch. millbrook-events.co.uk/event…
1
10
1
22
9,436
Replying to @CatalinPToma
Contemporary practice in HR-PCI (as per PROTECT III etc) is to remove the Impella (CP) after PCI in the cath lab - this is the strategy evaluated by @CHIP_BCIS3. Would post-PCI support help? 🤷🏽‍♂️ … but higher vascular comps/bleeding will need to be offset by possible gain
1
4
127
📣 @CHIP_BCIS3 NEWS 📰 Hemodynamic substudy @JACCJournals: physiology of high risk PCI; support ≠ protection authors.elsevier.com/a/1nZ0V… 🧐 @NEJM letters to editor+replies nejm.org/doi/full/10.1056/NE… 📺 @BCIS_uk Grand Rounds: Live discussion Wed 16 Sept 26. 👉🏼 millbrook-events.co.uk/event…
3
8
350
Out now @NEJM a deep dive into the methodology and implications of @CHIP_BCIS3! Read more to understand the value of hierarchical composites, why Win Ratio was suited to this trial, what Bayesian Analysis may have shown, tale home clinical messages👇🏽 nejm.org/doi/full/10.1056/NE…
2
1
7
822
Also, based on clinical features, the trial eligibility criteria identified a #SCAI A (at RISK of cardiogenic shock) cohort… v low cardiac output, limited reserve, frequent procedural hypotension. ➡️ @CHIP_BCIS3 criteria can be used to define High-Risk PCI
1
5
15
678
CHIP-BCIS3 retweeted
🫀 NEW in @JACCJournals — @CHIP_BCIS3 hemodynamic substudy Elective LV unloading in complex high-risk PCI: ❌ Did NOT prevent myocardial stunning ⚠️ More loss of pulse pressure → linked to myocardial injury ✅ Less vasoactive use 👇 authors.elsevier.com/a/1nZ0V…
4
21
1
56
8,152
CHIP-BCIS3 retweeted
Introducing BCIS Grand Rounds, a brand new webinar series bringing landmark clinical trials to life. Presented in a dynamic, podcast-style format with live audience Q&A. 🎙️CHIP – BCIS3 16 September | 17:30–18:30 Featuring @divaka_perera, Julian Gunn, Simon Ray, Jenny Rossington and Sohail Khan 👉Register: millbrook-events.co.uk/event… #InterventionalCardiology #Cardiology #CHIPBCIS3 #OPTIMALLM #ClinicalTrials
16
33
2,324
Late Breaking #EuroPCR2026: @CHIP_BCIS3 hemodynamic sub study to be presented on Thursday 21st May by @SaadEzad (funded by @TheBHF) ❓Does elective mAFP (Impella) prevent hemodynamic instability and reduce stunning ❓Do RHC metrics predict outcomes/identify mAFP responders
1
9
12
1,074
CHIP-BCIS3 retweeted
The mortality rate was higher in the mAFP arm. The PPMI doesn’t matter as much
3
1
1
15
5,027
We included ppMI in the composite primary outcome as our hypothesis was that mAFP use would protect the myocardium from injury. But it turned out myocardial injury was MORE likely with mAFP. ppMI was only used to determine wins in pairs tied on MACE… and favoured standard care
5
12
755
The pre-specified hierarchy of components in the primary outcome ensured mortality “trumped” other MACE, which trumped ppMI. Mortality was higher with mAFP and had the greatest impact on the Win Ratio (40% of pair-wise comparisons decided by death … and favoured standard care)
The mortality rate was higher in the mAFP arm. The PPMI doesn’t matter as much
2
10
26
3,766
P Vranckx, J Møller, G Tavazzi say routine use of elective MCS cannot be supported on the basis of @CHIP_BCIS3 but note modest sample size. doi.org/10.1093/ehjacc/zuag0… But isn’t it events that determine power? 221 of 300 pts experienced a composite primary outcome! (129 excl. ppMI)
2
9
1
13
6,296
CHIP-BCIS3 retweeted
🤝 3 multidisciplinary PCR Focus Groups are advancing cardiovascular care ⭐ Mechanical circulatory support ⭐ Mitral valve disease ⭐ Tricuspid valve disease 🎥 Prof. F. Maisano explains how → pcronline.com/Network/PCR-Fo… #interventionalcardiology #cardiology
1
11
840
CHIP-BCIS3 retweeted
Original Article: Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention (CHIP-BCIS3 trial) nejm.org/doi/full/10.1056/NE… Editorial: Price of Protection — Microaxial Flow Pump in High-Risk PCI nejm.org/doi/full/10.1056/NE… #ACC26 | @ACCinTouch
11
1
32
8,184